NCI Director Is M.D. Anderson Prostate Cancer Expert Von Eschenbach
This article was originally published in The Gray Sheet
The new director of the National Cancer Institute will be M.D. Anderson Cancer Center prostate cancer expert Andrew von Eschenbach, MD. President Bush announced his appointment Dec. 7
You may also be interested in...
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA neuroscientist Andrew Shen.
The templates from the US agency provide guidance to manufacturers developing antibody tests for clinical or at-home use.